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Brain serotonin (5-HT) plays a key role in aggressive behaviours and related psychopathologies, but 
its precise mechanism of action remains elusive. Genetic animal models may provide a tool to 
elucidate the relationship between aggression and serotonin. The present study showed that 
tryptophan hydroxylase 2 (Tph2) knockout (KO) rats, which exhibit profoundly diminished 
extracellular serotonin levels, display increased aggressiveness compared to their Tph2 wildtype 
(WT) counterparts. However, the level of aggression in Tph2 KO rats did not equal that of feral wild 
type Groningen (WTG) rats. To investigate whether enhanced 5-HT1A receptor functionality may be 
present in Tph2 KO rats, we tested the acute anti-aggressive potency of the highly selective 5-HT1A 
receptor full agonist NLX-112 (a.k.a. befiradol or F13640). Data show that compared to Tph2 WT and 
WTG rats, the NLX-112 dose-effect curve was shifted to the right in Tph2 KO animals. These results 
suggest that, unlike previous reports in Tph2 KO mice, Tph2 KO rats have a decreased 5-HT1A 
receptor sensitivity compared to both Tph2 WT and WTG animals.   















There is a clear association between aggressive behaviour and the neurotransmitter serotonin (5-
hydroxytryptamine, 5-HT), but the functional complexity of the serotonergic system makes the 
precise role unclear. Although an inverse relation between basal brain 5-HT levels and aggression is 
inferred from a vast database of both human (see Duke, Bègue, Bell, & Eisenlohr-Moul, 2013 for 
meta-analysis) and animal research (Carrillo et al., 2009; Comai et al., 2012; Takahashi et al., 2011), 
this simple serotonin-deficiency hypothesis of exaggerated aggression is gradually being revised by a 
conceptual framework that accommodates the increasing knowledge about the complex modulatory 
and regulatory mechanisms of brain 5-HT activity (De Boer and Newman-Tancredi, 2016; Montoya et 
al., 2012; Olivier, 2004; Rosell and Siever, 2015). 
In line with the inverse relationship between 5-HT and aggression, animals chronically treated with 
selective serotonin reuptake inhibitors (SSRIs) (Caldwell and Miczek, 2008; Perreault et al., 2003; 
Pinna et al., 2003; Sánchez and Meier, 1997) as well as genetically modified serotonin transporter 
(SERT) knockout mice and rats (Holmes et al., 2002; Homberg et al., 2007) show decreased 
aggression together with enhanced brain 5-HT levels. Accordingly, genetically modified tryptophan 
hydroxylase 2 (Tph2) knockout (KO) mice that show profoundly decreased amounts of brain 5-HT 
levels, due to the absence of the central nervous system specific and rate-limiting enzyme Tph2, 
demonstrate exaggerated aggressive behavior (Mosienko et al., 2012). Despite the absence of brain 
5-HT synthesis, serotonergic markers other than Tph2 are preserved in these animals (Gutknecht et 
al., 2012, 2008; Kriegebaum et al., 2010).  
Among the multiple mechanisms that control 5-HT neurotransmission, the 5-HT1A receptor subtype 
plays a prominent role as shown in both human (Coccaro et al., 1990; Parsey et al., 2002; Witte et al., 
2009) and animal research (de Boer and Koolhaas, 2005; Korte et al., 1996; Miczek et al., 1998; 
Takahashi et al., 2011). This receptor is just as 5-HT itself well conserved among mammalian species 
(Nichols, David E., 2008) and crucially important in regulating serotonergic neuronal (re)activity and 
consequent 5-HT transmitter synthesis and release processes via its direct (i.e., short-loop 
somatodendritic autoreceptor function) and indirect (i.e., long-loop heteroreceptor) inhibitory feed-
back action on 5-HT neuronal firing (Celada et al., 2001; Hajo and Sharp, 1999; Pineyro and Blier, 
1999). Specifically, inhibitory 5-HT1A autoreceptors have been suggested in animal studies to have an 
important causal role in aggressive responding and in mediating the robust anti-aggressive actions of 
5-HT1A receptor agonists (Cooper et al., 2009; de Boer et al., 2000; de Boer and Koolhaas, 2005; De 













High trait-like aggressive rats and mice are characterized by enhanced somatodendritic 5-HT1A 
autoreceptor sensitivity (Caramaschi et al., 2007; Cooper et al., 2009; de Boer and Koolhaas, 2005; 
De Boer and Newman-Tancredi, 2016; Schiller et al., 2006). Accordingly, the diminished aggressive 
phenotype of SERT deficient rats and mice (Holmes et al., 2002; Homberg et al., 2007) is associated 
with a sustained increase in extracellular serotonin levels, which could be enabled by desensitization 
of 5-HT1A autoreceptors (Homberg et al., 2008; Snoeren, 2010). In addition, transgenic mice with 
conditional overexpression of somatodendritic 5-HT1A autoreceptors exhibit a hyper-aggressive 
behavioral phenotype (Audero et al., 2013). Finally, enhanced 5-HT1A autoreceptor functioning as 
shown by decreased neuron firing after 5-HT1A agonist administration was recently reported in Tph2 
KO mice that demonstrate high aggressiveness (Araragi et al., 2013; Mlinar et al., 2017). 
In contrast to the association between high aggression, low tonic 5-HT and increased 5-HT1A 
autoreceptor functioning, 5-HT1A receptor agonists show robust anti-aggressive effects in rodents (de 
Boer et al., 2000; de Boer and Koolhaas, 2005; Miczek et al., 1998; Sakaue et al., 2002). Although 
current techniques are unsuited to measure 5-HT levels during an aggressive interaction, it was 
shown that shortly after an aggressive encounter extracellular 5-HT decreased in the prefrontal 
cortex (van Erp and Miczek, 2000). Therefore, it is likely that 5-HT levels may increase right before or 
during this acute state of arousal (Beekman et al., 2005; de Boer et al., 2000). Thus, the acute anti-
aggressive effect of systemic 5-HT1A receptor agonists is considered to be largely expressed via their 
efficacious action on the inhibitory autoreceptors located on the soma and dendrites of raphe 5-HT 
neurons, by attenuating conflict-activated 5-HT neuronal activity in rodent studies (De Almeida and 
Lucion, 1997; De Boer and Newman-Tancredi, 2016; Mos et al., 1993). Indeed, direct 
pharmacological activation of 5-HT1A autoreceptors in the dorsal raphe nucleus employing local 
microinjection of 5-HT1A agonists that potently suppress 5-HT neuronal activity, consistently reduced 
aggressive behavior in mice and rats (De Almeida and Lucion, 1997; Mos et al., 1993; van der Vegt et 
al., 2003). However, also local microinjection of a 5-HT1A agonist in the ventral orbital prefrontal 
cortex reduced aggression in mice (Centenaro et al., 2008; Stein et al., 2013). So targeting both pre- 
and postsynaptic 5-HT1A receptors may be a good strategy to decrease aggressive behavior.     
In the present study we aimed to further elucidate 5-HT1A receptor functioning as shown by 
decreased aggressive behavior in relation to basal levels of brain 5-HT availability. We used the 
recently generated Tph2 KO rat model that is deficient in brain 5-HT synthesis and levels (Kaplan et 
al., 2016).   
Their anticipated elevated aggressive phenotype was compared to the aggression levels of a feral 
strain of wild-type Groningen (WTG) rats, which demonstrate considerable higher levels of offensive 













functional activity of 5-HT1A receptors, the anti-aggressive potency of the novel highly selective 5-
HT1A receptor agonist NLX-112 was determined and compared among the rat strains. We expected 
an enhanced 5-HT1A receptor sensitivity in these high aggressive Tph2 KO rats in comparison to both 
Tph2 WT and WTG rats, due to their increased aggression and absent brain 5-HT availability.  
2. Materials and methods  
2.1 Animals  
2.1.1 Tph2 KO and WT rats  
Nine Tph2 knockout (KO) (weight 237 ± 35 g) and nine Tph2 wildtype (WT) (247 ± 12 g) rats of 4-5 
months of age were used as residents in the acute dose response experiments. These animals were 
outcrossed for at least 10 generations with wild type Dark Agouti rats (Envigo, The Netherlands). 
Eighteen Dark Agouti OlaHsd female rats (167±14 g) (Envigo; Horst, the Netherlands) were used as 
housing companions together with the residents to avoid social isolation and to facilitate territorial 
behavior. These pairs stayed the same during the course of all experiments, to reduce stress of an 
unfamiliar partner. Thirty-six Dark Agouti OlaHsd male rats (205±21 g) (Envigo; Horst, The 
Netherlands) were used as intruders in the resident-intruder test.  
2.1.2 WTG rats  
Twenty-four Wild type Groningen (WTG) 4-5 months of age (435 ± 5 g) rats (Rattus Norvegicus; 
originally wild-trapped animals bred under conventionalized conditions for 52 generations) were 
used as residents in the acute dose response experiments. Oviduct-ligated WTG female rats (327 ± 6 
g) were used as housing companions to avoid social isolation and to facilitate territorial behavior. 
These pairs stayed the same during the course of all experiments, to reduce stress of an unfamiliar 
partner. Group-housed male WTG rats (426 ± 7 g) were used as intruders in the resident-intruder 
test.  
All animals were housed in temperature (21±1 °C) and humidity-controlled (45-60% relative 
humidity) rooms, with a 12 h reversed light-dark cycle (lights on at 8:00 PM). Experiments were 
performed in the dark-phase between 9:00 AM and 5:00 PM. Animals were housed under standard 
social housing conditions in type IV open cages (48 x 38 x 21 cm), unless stated otherwise. For all 
cages sawdust bedding and cage enrichment was provided, and the animals had ad libitum access to 
water and rodent chow (V1534, Sniff, long-cut pellet, Bio Services, Uden, The Netherlands).  
All experiments were approved by the Committee for Animal Experiments of the Radboud University 
Nijmegen Medical Centre, Nijmegen, The Netherlands, and the Groningen University, Groningen, The 
Netherlands. All efforts were made to minimize animal suffering and to reduce the number of 













2.2 Drugs  
NLX-112 (F13640; befiradol) fumarate was supplied by Neurolixis Inc. (Dana Point, CA, USA). This 
novel agonist is an interesting alternative to previous 5-HT1A receptor agonists as it shows nanomolar 
affinity, high selectivity and increased efficacy at 5-HT1A receptors (Colpaert et al., 2002; Newman-
Tancredi et al., 2017). NLX-112 was administered 20 min before the start of the resident intruder 
interaction either via intraperitoneal (i.p.) administration (Tph2 KO and WT experiments) or 
subcutaneous (s.c.) administration (WTG experiments). In between the drug test-days three washout 
days were scheduled where the animals were left undisturbed. Every animal received all six 
treatments (i.e. vehicle, 0.01, 0.04, 0.16, 0.63 and 2.5 mg/kg bodyweight) of NLX-112 in a random 
order. Six different treatment order groups were created, and the 18 Tph2 and 24 WTG animals were 
randomly assigned to these groups. This resulted respectively in three and four animals per 
treatment order group. In this way a block design of six different treatments and six different 
treatment order groups (including three or four animals per group) was created. Doses are expressed 
as mg/kg of the drug base.  
2.3 Experimental procedures 
2.3.1 Resident intruder test  
An adapted version of the resident-intruder paradigm was used as described by Koolhaas et al., 2013. 
One week before the experiment male residents were housed together with companion females in a 
PhenoTyper 4500 cage (45x45x55 cm; Tph2 KO and WT rats) (Noldus, Wageningen, the Netherlands) 
or large observation cage (80 x 55 x 50 cm; WTG rats) to allow sufficient space for the full range of 
aggressive behaviors during the aggressive interactions. Females were sterilized by ligation of the 
oviducts, to keep them hormonally intact and receptive for the males. Bedding material was not 
cleaned during the experiment to ensure an undisturbed territory.   
After one week of habituation, the baseline level of offensive behavior was tested on 3 consecutive 
days during maximally a 10 min confrontation with an unfamiliar male conspecific in the home 
territory of the experimental rat. The female partner of the experimental rat was removed from the 
observation cage approximately 60 min prior to the start of this social provocation test. During the 
first 3 tests, the intruder was removed immediately after the first attack from the resident occurred, 
and the attack latency time (ALT) was noted. When no attack occurred within 10 min the intruder 
was removed and an attack latency time of 600 s was scored. Experimental groups were balanced on 
the basis of the ALT and the level of offensive behavior performed during the fourth baseline test 













interaction, females and cage accessories were returned and animals were left undisturbed until the 
next test day. 
During the resident-intruder agonistic confrontations on the non-drug test-days and on the drug test-
days, the full range of behaviors of the experimental resident was video recorded and manually 
scored offline using Observer XT12 (Noldus, Wageningen, the Netherlands) by an experimenter blind 
to treatment conditions. An extensive description of the different behavioral elements displayed 
during agonistic interactions has been reported previously (De Boer et al., 2003; Koolhaas et al., 
2013) Briefly, the following behavioral elements are distinguished: 1) lateral threat; 2) keep down; 3) 
clinch attack; 4) chase; 5) offensive upright; 6) offensive move towards; 7) mounting; 8) social 
behavior; 9) submissive behavior; 10) other no contact behaviors. The durations of the different 
behavioral elements were determined and expressed as a percentage of the total 10 minutes of the 
confrontation. To promote a clear representation of the data, the elements lateral threat, keep 
down, clinch attack, chase, offensive upright, offensive move towards and mounting are taken as one 
behavioral category, i.e., percentage of time showing aggressive behavior. Also the latency time to 
the first attack by the resident was taken as a measure of aggressive initiative/motivation. The term 
social behavior describes behavior initiated by the resident and describes social move towards 
behavior, social upright behavior, ano-genital sniffing and all other direct contact between animals 
such as sniffing and grooming.  
2.4 Statistical analysis  
Independent t-tests were applied to compare baseline aggression levels between Tph2 KO and WT 
animals. To compare effects of different doses on ‘aggressive behavior’, ‘attack latency’ and ‘social 
behavior’ we used a linear mixed model using NLX-112 dose as the within-subject factor (i.e., vehicle, 
0.01, 0.04, 0.16, 0.63 and 2.5 mg/kg), time (the sequential number of test days for each drug dose 
(i.e. 0-6)) as covariate factor and for the Tph2 study, genotype (i.e. Tph2 KO and WT) as between-
subject factor. Post-hoc comparisons between genotypes were performed using an independent 
samples t-test, and dependent samples t-tests were used to compare between doses within groups. 
In the dose-response studies, the drug effects on aggressive behavior were also computed as 
percentage of the respective vehicle-treated control values to enable comparisons between the 
various animal strains using a linear mixed model with NLX-112 dose (i.e., vehicle, 0.01, 0.04, 0.16, 
0.63 and 2.5 mg/kg) as the within-subject factor, group (i.e. WTG, Tph2 KO and WT) as between-
subject factor and time (the sequential number of test days for each drug dose (i.e. 0-6)) as covariate 
factor. Post-hoc comparisons between the three groups were done using Tukey’s HSD test. Log-
logistic analysis was used to estimate the dose of NLX-112 to decrease aggression by 50% (ED50) 













the optimal curve fit (Three Parameters Logistic Regression (Finney and Tattersfield, 1952)) in the 
add-on package drc (version 3.0-1) in RStudio (version 1.0.153, 2009-2017). All other statistical 
analyses were performed using SPSS version 23 (SPSS Inc., Chicago, IL, USA). All data were checked 
for outliers and normality (using the Shapiro–Wilkinson test). All statistical tests were performed 
two-sided. All results are expressed as average values ± SEM (standard error of the mean), unless 
stated differently. Level of significance was set at p < 0.05 and 0.05<p≤0.08 was considered as a 
trend of significance. 
3. Results 
3.1 Genotype effect baseline aggression 
At the start of the experiment, resident-intruder tests were repeated three times to establish a 
stable aggression level. At the fourth test day a full repertoire of aggressive behaviors was recorded 
to quantify the baseline aggression level. Tph2 KO animals showed increased time spent on 
aggressive behavior (t(9.35)=2.93, p=0.016) and a decreased attack latency (t(13.63)=-2.55, p=0.023) 
compared to Tph2 WT animals (see Figure 1).  
 
  Figure 1: Baseline aggressive behavior expressed as A) time spent on aggressive behavior (%) and B) attack 
latency (s) per genotype (Tph2 KO n=9, Tph2 WT n=9) in a ten-minute interaction represented as mean (±SEM). 
Significant genotype effects indicated by * (p<0.05). 
3.2 Acute anti-aggressive effect NLX-112 in Tph2 KO vs. WT animals 
Three days after the last baseline resident-intruder test, animals were subjected to a randomized 
NLX-112 dose-response treatment regimen to test for effects on ‘aggressive behavior’, ‘attack 













There was a significant overall main effect of Tph2 genotype on time spent on aggressive behavior 
(F(1, 91)=8.56, p=0.004) and social behavior (F(1,91)=3.87, p=0.052), whereas this did not reach 
significance for attack latency (F(1,91)=3.12, p=0.081). Post-hoc tests revealed an increase in 
aggression (t(8)=2.63, p=0.030) and a decrease in social behavior (t(10,70)=2.27, p=0.045) in KO as 
compared to WT rats at dose 0.16 mg/kg.   
Main effects of NLX-112 doses were found for time spent on aggression (F(5,91)=2.74, p=0.024), 
attack latency (F(5,91)=6.76, p<0.001) and time spent on social behavior (F(5, 91)=2.69, p=0.026). 
  
Aggressive behavior decreased relative to the basal levels seen under vehicle treatment for doses 
0.63 (t(8)=2.57, p=0.033) and 2.5 (t(8)=3.48, p=0.008) mg/kg in KO animals. Decreases in aggressive 
behavior between consecutive doses were found for 0.16-0.63 (t(8)=2.47, p=0.039) and 0.63-2.5 
(t(8)=2.44, p=0.041) mg/kg in KO animals. The only difference in aggressive behavior between doses 
in WT animals was found between 0.04-0.16 (t(8)=3.60, p=0.007) mg/kg.   
An increase in attack latency was found only consecutively for 0.01-0.04 mg/kg in KO animals (t(8)=-
2.26, p=0.053), whereas this did not reach significance for WT animals (t(8)=-2.02, p=0.078).   
Social behavior in KO animals increased relative to the basal levels seen under vehicle treatment for 
doses 0.01 (t(8)=-3.69, p=0.006), 0.16 (t(8)=-5.60, p<0.001), and 0.63 (t(8)=-2.89, p=0.020). Further 
consecutive dose differences in social behavior were found between doses 0.63-2.5 (t(8)=3.09, 
p=0.015) mg/kg, where time spent on social behavior decreased in KO animals. No differences were 














Figure 2: Effect of different dosages of NLX-112 (vehicle, 0.01, 0.04, 0.16, 0.63, 2.5 mg/kg bodyweight) on A) 
time spent on aggressive behavior, B) attack latency and C) time spent on social behavior in resident Tph2 KO 
(n=9) and resident Tph2 WT (n=9) rats during a ten-minute interaction with an intruder animal. Data are 
represented as mean (±SEM). G indicates an overall genotype effect (p<0.05) and D indicates an overall dose 
effect (p<0.05). Post-hoc tests reveal significant genotype effects (*p<0.05), significant dose effects (
#
p<0.05) 
and doses significantly different from 0.00 mg/kg (
$
p<0.05). 
3.3 Acute anti-aggressive effect NLX-112 in WTG animals 
In WTG animals, dose effects of NLX-112 were found in time spent on aggressive behavior 
(F(5,132)=15.75, p<0.001), attack latency (F5,132)=21.85, p<0.001) and time spent on social behavior 
(F(5,132)=8.72, p<0.001) (see Figure 3).   
Relative to basal levels seen under vehicle treatment, aggression decreased at doses 0.16 
(t(23)=5.39, p<0.001), 0.63 (t(23)=6.48, p<0.001) and 2.5 (t(23)=5.65, p<0.001) mg/kg. Consecutive 













(t(23)=2.19, p=0.039) mg/kg, where aggression decreased.  
Relative to basal levels seen under vehicle treatment, attack latency increased at doses 0.16 (t(22)=-
5.94, p<0.001), 0.63 (t(22)=-6.79, p<0.001) and 2.5 (t(22)=-6.64, p<0.001) mg/kg. Finally, an increase 
in attack latency (t(23)=-6.65, p<0.001) was found for 0.04-0.16 mg/kg.  
Social behavior increased compared to basal levels seen under vehicle treatment at doses 0.16 
(t(22)=-5.16, p<0.001), 0.63 (t(22)=-5.35, p<0.001) and 2.5 (t(22)=-3.76, p<0.001) mg/kg. 
Furthermore, an increase in social behavior was found at dose 0.04-0.16 mg/kg (t(23)=-5.02, 
p<0.001).  
No time effects were found.  
Figure 3: Effect of different dosages of NLX-112 (vehicle, 0.01, 0.04, 0.16, 0.63, 2.5 mg/kg bodyweight) on A) 
time spent on aggressive behavior, B) attack latency and C) time spent on social behavior in resident WTG rats 
(n=24) during a ten-minute interaction with an intruder animal. Data are represented as mean (±SEM). D 
indicates an overall dose effect (p<0.05). Post-hoc tests reveal significant dose effects (
#
p<0.05) and doses 
significantly different from 0.00 mg/kg (
$
p<0.05).  













NLX-112 dose-effect curves were constructed by expressing aggressive behavior relative to the 
vehicle treatment (0 mg/kg bodyweight) to reliably compare the anti-aggressive potencies of NLX-
112 between the different groups (e.g. Tph2 KO, Tph2 WT and WTG animals) (see Figure 4). A trend 
for a dose x group interaction was found (F(8,190)=1.93, p=0.058). Although this interaction was not 
significant, the dose-effect curve could be considered shifted rightward in the Tph2 KO as compared 
to the Tph2 WT and WTG. Furthermore, main effects for group (F(2,190)=11, p<0.001) and for dose 
(F(4,190)=10.67, p<0.001) were found. No time effect was found. Post hoc tests revealed an 
increased level of corrected aggressive behavior averaged over all NLX-112 doses in Tph2 KO animals 
when compared to Tph2 WT animals (p=0.001) and WTG animals (p<0.001). ED50 values for WTG, 
Tph2 WT and Tph2 KO animals were 0.13, 0.05 and 0.50 mg/kg respectively.  
 
Figure 4: Aggressive behavior per dosage of NLX-112 (0.01, 0.04, 0.16, 0.63, 2.5 mg/kg bodyweight) expressed 
as percentage of aggressive behavior relative to vehicle (0 mg/kg bodyweight). Data are represented as mean 
(±SEM), G indicates an overall group effect (p<0.05) and D indicates an overall dose effect (p<0.05) and & 
indicates a trend (p<0.06) in dose*group interaction.  
4. Discussion 
The present study is the first, to our knowledge, to compare the aggressive behavior of Tph2KO and 
Tph2 WT rats. Several findings emerge from this study: firstly, the results indicate an enhanced 
aggressive phenotype in Tph2 KO, in comparison with Tph2 WT rats, as was anticipated based on the 
previously reported exaggerated aggressiveness in Tph2 KO mice (Mosienko et al., 2012).  However, 
when compared to feral WTG rats, their aggression level is still significantly lower, and thus cannot 













selective 5-HT1A receptor agonist NLX-112 was found. Despite the even more pronounced difference 
in levels of aggressiveness between Tph2 WT and WTG rats, the dose-effect relationships appeared 
similar. Surprisingly however, and in contrast to what was expected, higher doses of NLX-112 were 
needed to reach the same anti-aggressive effect in the low serotonin Tph2 KO animals. This 
rightward shift in aggressive behavior in the dose-effect curve, suggests that 5-HT1A receptor 
sensitivity is decreased in Tph2 KO rats compared to their WT counterparts and WTG rats. 
This latter finding seems at odds with recent reports from literature where Tph2 KO mice 
demonstrate increased 5-HT1A autoreceptor sensitivity. In these mice, lacking brain 5-HT synthesis, 
the mixed 5-HT1A/7 receptor agonist 8-OHDPAT was shown to exert a higher suppression of 
serotonergic neuron firing, indicating increased 5-HT1A autoreceptor sensitivity (Araragi et al., 2013; 
Mlinar et al., 2017). This increase could not be explained by upregulation of 5-HT1A receptor 
expression, as data on this is shown to be inconsistent in Tph2 KO mice (Angoa-Pérez et al., 2012; 
Gutknecht et al., 2012; Jacobsen et al., 2012; Kim et al., 2014; Kriegebaum et al., 2010; Mosienko et 
al., 2014). However, a recent study in Tph2 KO mice showed that receptor expression is regulated 
independently of receptor functionality. Indeed, an increased functional coupling of 5-HT1A 
autoreceptors to their principal effectors, G protein-coupled inwardly- rectifying potassium (GIRK) 
channels was observed, in the absence of an increase in 5-HT1A receptor density (Mlinar et al., 2017). 
Although serotonergic system formation seems to be normal in Tph2 KO mice (Gutknecht et al., 
2012, 2008; Kriegebaum et al., 2010), the absence of brain 5-HT synthesis has been shown to 
decrease the number and density of GABAergic interneurons in the anterior basolateral amygdala 
(Waider et al., 2013). These interneurons are regulated by excitatory projections from the PFC, which 
are in turn regulated by the 5-HT1A receptor (Jüngling et al., 2008; Quirk et al., 2003). Decreases in 
GABAergic interneurons may lead to a compensatory decrease in sensitivity of the presynaptic 5-HT1A 
autoreceptors, thereby providing diminished serotonergic negative feedback inhibitory control. If 
such mechanisms are combined with a compensatory increase in postsynaptic 5-HT1A receptor 
sensitivity, this would enable stabilization of serotonergic signaling in Tph2 KO animals. Obviously, 
further research is needed to resolve the seemingly opposite developmental adaptation mechanisms 
of 5-HT1A autoreceptor sensitivity between rats and mice deficient in brain serotonin. 
The Tph2 KO results in this study support an association between low 5-HT1A receptor sensitivity and 
aggression. This is in line with findings in Norway rats bred for high affective aggressiveness, where a 
significant decrease in 5-HT1A receptor binding in frontal cortex, hypothalamus and amygdala was 
found (Popova et al., 2005). In apparent clinical confirmation of these experimental findings, life-time 













binding in vivo in several brain regions (amongst others amygdala, dorsal raphe nucleus, orbital PFC) 
(Parsey et al., 2002). In contrast, another study in healthy human subjects showed a positive 
correlation between aggression and prefrontal 5-HT1A binding potential as shown by PET scan (Witte 
et al., 2009). This is further supported by several studies in which enhanced postsynaptic receptor 
sensitivity was associated with high aggression in rodents (Korte et al., 1996; van der Vegt et al., 
2001). These discrepancies might underlie the differences in 5-HT1A receptor sensitivity and 
aggression shown here.  
We showed an overall robust anti-aggressive effect of the 5-HT1A receptor agonist NLX-112. This 
novel compound exhibits both high selectivity for the 5-HT1A receptor as well as high agonist efficacy  
(Colpaert et al., 2002; Newman-Tancredi et al., 2017). As was shown here, these characteristics 
resulted in a specific anti-aggressive effect in Tph2 KO and WTG rats, while social behavior increased 
or stayed similar relative to the vehicle, indicating no major sedative or locomotor impairing effects 
of the drug treatment. A limitation of the present study is the relatively low aggressive behavior in 
Tph2 KO animals compared to baseline WTG aggression levels. This discrepancy could be explained 
by the increased anxiety found in the Dark Agouti background of Tph2 animals (Mechan et al., 2002), 
making the animals more vulnerable to stress from handling during injections. Furthermore, different 
routes of administration were used for the Tph2 (i.p.) and WTG (s.c.) experiments. Since both groups 
were habituated to the methods, no additional difference in stress of injection would be expected 
between the groups (Turner et al., 2011). Future studies should compare within one administration 
route and add a higher number of dosages, especially between 0.04-0.63 mg/kg, to provide a more 
exact dose-effect curve of aggressive behavior. 
In conclusion, the robust anti-aggressive effect of the specific 5-HT1A receptor agonist NLX-112 is 
demonstrated in Tph2 KO and WTG rats. This finding underlines the importance of the 5-HT1A 
receptor in controlling aggressive behavior during an acute conflict situation, and demonstrates the 
potential to use the 5-HT1A agonist NLX-112 (which is currently in clinical development) as a specific 
anti-aggressive treatment. The observation that high aggressive Tph2 KO rats show an increase in 
effective NLX-112 dose as compared to Tph2 WT and WTG animals, is indicative for a reduced 5-HT1A 
autoreceptor sensitivity. It seems that receptor sensitivity in the absence of 5-HT plays an important 
role in aggressive behavior itself and its treatment. The current study suggests that 5-HT1A receptor 
sensitivity in Tph2 KO rats is decreased compared to both Tph2 WT and WTG animals as opposed to 
previous reports in Tph2 KO mice, and that underlying mechanisms have to be further elucidated in 
future studies.   
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- Tph2 KO rats show increased aggressive behaviour compared to their WT counterparts 
- The 5-HT1A receptor agonist NLX-112 shows a robust anti-aggressive effect  
- The dose-effect curve shifts rightward in Tph2 KO as compared to WT and WTG rats 
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